BIG PHARMA CONTROL: Drug Companies Use "Private Research Companies" Over Academic Medical Research

From 1991 to 2004, drug company funding for academic medical research shifted from 80% to 26% as they opted for “Private Research Companies.” This shifting provided a way for drug companies to control medical studies’ conduct and agenda.